SCHRODINGER INC (SDGR) Stock Fundamental Analysis
USA - NASDAQ:SDGR - US80810D1037 - Common Stock
18.3 USD
+0.01 (+0.05%)
18.48 USD
+0.18 (+0.98%)
Taking everything into account, SDGR scores 3 out of 10 in our fundamental rating. SDGR was compared to 35 industry peers in the Health Care Technology industry. No worries on liquidiy or solvency for SDGR as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, SDGR is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SDGR had negative earnings in the past year.
SDGR had a negative operating cash flow in the past year.
In the past 5 years SDGR reported 4 times negative net income.
SDGR had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
SDGR has a Return On Assets (-26.92%) which is comparable to the rest of the industry.
SDGR has a Return On Equity (-54.77%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.92% | ||
| ROE | -54.77% | ||
| ROIC | N/A |
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of SDGR (58.16%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of SDGR has grown nicely.
SDGR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 58.16% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
SDGR does not have a ROIC to compare to the WACC, probably because it is not profitable.
SDGR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for SDGR has been increased compared to 5 years ago.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
Based on the Altman-Z score of 1.15, we must say that SDGR is in the distress zone and has some risk of bankruptcy.
SDGR has a Altman-Z score (1.15) which is in line with its industry peers.
SDGR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.15 |
ROIC/WACCN/A
WACC10.25%
2.3 Liquidity
A Current Ratio of 3.25 indicates that SDGR has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.25, SDGR is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
SDGR has a Quick Ratio of 3.25. This indicates that SDGR is financially healthy and has no problem in meeting its short term obligations.
SDGR's Quick ratio of 3.25 is fine compared to the rest of the industry. SDGR outperforms 77.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.25 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 0.82% over the past year.
The Revenue has grown by 32.90% in the past year. This is a very strong growth!
The Revenue has been growing by 19.41% on average over the past years. This is quite good.
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
3.2 Future
SDGR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.08% yearly.
The Revenue is expected to grow by 19.52% on average over the next years. This is quite good.
EPS Next Y7.29%
EPS Next 2Y12.07%
EPS Next 3Y12.08%
EPS Next 5YN/A
Revenue Next Year23.48%
Revenue Next 2Y21.65%
Revenue Next 3Y17.28%
Revenue Next 5Y19.52%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SDGR. In the last year negative earnings were reported.
Also next year SDGR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
SDGR's earnings are expected to grow with 12.08% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.07%
EPS Next 3Y12.08%
5. Dividend
5.1 Amount
SDGR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
18.3
+0.01 (+0.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners108.15%
Inst Owner Change1.31%
Ins Owners2.65%
Ins Owner Change0.79%
Market Cap1.35B
Revenue(TTM)256.95M
Net Income(TTM)-175.99M
Analysts80
Price Target27.65 (51.09%)
Short Float %15.36%
Short Ratio8.63
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.11%
Min EPS beat(2)24.66%
Max EPS beat(2)37.55%
EPS beat(4)2
Avg EPS beat(4)6.54%
Min EPS beat(4)-28.59%
Max EPS beat(4)37.55%
EPS beat(8)5
Avg EPS beat(8)6.18%
EPS beat(12)8
Avg EPS beat(12)16.99%
EPS beat(16)10
Avg EPS beat(16)13.2%
Revenue beat(2)2
Avg Revenue beat(2)3.27%
Min Revenue beat(2)3.23%
Max Revenue beat(2)3.3%
Revenue beat(4)4
Avg Revenue beat(4)4.36%
Min Revenue beat(4)3.23%
Max Revenue beat(4)6.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.23%
Revenue beat(12)7
Avg Revenue beat(12)1.23%
Revenue beat(16)11
Avg Revenue beat(16)6.23%
PT rev (1m)-3.56%
PT rev (3m)-13.17%
EPS NQ rev (1m)4.13%
EPS NQ rev (3m)11.71%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)11.33%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)2.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 5.24 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 4.19 | ||
| P/tB | 4.26 | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.41
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS3.49
BVpS4.37
TBVpS4.3
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -26.92% | ||
| ROE | -54.77% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 58.16% | ||
| FCFM | N/A |
ROA(3y)-13.11%
ROA(5y)-11.18%
ROE(3y)-23.43%
ROE(5y)-18.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.19%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.39
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 35.82% | ||
| Cap/Sales | 0.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.25 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 1.15 |
F-Score3
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)181.56%
Cap/Depr(5y)173.13%
Cap/Sales(3y)4.71%
Cap/Sales(5y)4.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.46%
EPS Next Y7.29%
EPS Next 2Y12.07%
EPS Next 3Y12.08%
EPS Next 5YN/A
Revenue 1Y (TTM)32.9%
Revenue growth 3Y14.6%
Revenue growth 5Y19.41%
Sales Q2Q%53.94%
Revenue Next Year23.48%
Revenue Next 2Y21.65%
Revenue Next 3Y17.28%
Revenue Next 5Y19.52%
EBIT growth 1Y21.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.01%
EBIT Next 3Y17.97%
EBIT Next 5YN/A
FCF growth 1Y97.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y99.1%
OCF growth 3YN/A
OCF growth 5YN/A
SCHRODINGER INC / SDGR FAQ
What is the ChartMill fundamental rating of SCHRODINGER INC (SDGR) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SDGR.
What is the valuation status of SCHRODINGER INC (SDGR) stock?
ChartMill assigns a valuation rating of 0 / 10 to SCHRODINGER INC (SDGR). This can be considered as Overvalued.
What is the profitability of SDGR stock?
SCHRODINGER INC (SDGR) has a profitability rating of 1 / 10.
Can you provide the financial health for SDGR stock?
The financial health rating of SCHRODINGER INC (SDGR) is 7 / 10.
What is the earnings growth outlook for SCHRODINGER INC?
The Earnings per Share (EPS) of SCHRODINGER INC (SDGR) is expected to grow by 7.29% in the next year.